mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.7 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.7 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.7 |